WHITEHAWK THERAPEUTICS, INC. (WHWK) Operating Margin
- Operating margin · 12 months: Value (m); Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | (m) | Operating income / revenue. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -86.06M USD | Operating Income (Loss) |
| Revenue | 0.00 USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 0.00 USD | Cost of Goods and Services Sold |
| Research and development | 63.49M USD | Research and Development Expense |
| Selling, general and administration | 22.57M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $-86.06M | $0.00 | $0.00 | $63.49M | $22.57M | (m) |
| 2026-03-31 | $-122.70M | $0.00 | $0.00 | $99.41M | $23.30M | (m) |
| 2025-12-31 | $-114.40M | $7.14M | $760.00K | $90.96M | $29.82M | -1601.12% |
| 2025-09-30 | $-108.46M | $14.38M | $1.55M | $86.29M | $35.01M | -754.05% |
| 2025-06-30 | $-102.33M | $21.60M | $2.35M | $81.94M | $36.99M | -473.83% |
| 2025-03-31 | $-63.16M | $27.77M | $3.13M | $46.23M | $38.94M | -227.41% |
| 2024-12-31 | $-67.46M | $25.98M | $3.02M | $51.03M | $36.75M | -259.62% |
| 2024-09-30 | $-66.22M | $25.07M | $3.16M | $49.45M | $36.04M | -264.15% |
| 2024-06-30 | $-70.66M | $23.82M | $3.05M | $51.34M | $40.08M | -296.67% |
| 2024-03-31 | $-74.62M | $23.84M | $2.93M | $51.57M | $43.96M | -313.00% |
| 2023-12-31 | $-71.93M | $24.35M | $2.81M | $48.93M | $44.55M | -295.36% |
| 2023-09-30 | $-69.69M | $23.25M | $2.10M | $45.53M | $45.31M | -299.68% |
| 2023-06-30 | $-66.88M | $21.54M | $2.00M | $42.41M | $44.01M | -310.47% |
| 2023-03-31 | $-65.69M | $18.78M | $1.69M | $36.82M | $42.23M | -349.87% |
| 2022-12-31 | $-62.68M | $15.22M | $1.33M | $32.66M | $40.18M | -411.94% |
| 2022-09-30 | $-63.15M | $10.99M | (m) | $30.52M | (m) | -574.70% |
| 2022-06-30 | $-135.43M | $6.74M | (m) | $27.50M | (m) | -2008.13% |
| 2022-03-31 | $-120.94M | $3.31M | (m) | $22.82M | (m) | -3657.21% |
| 2021-12-31 | $-111.22M | $1.12M | (m) | $19.67M | (m) | -9930.09% |
| 2021-09-30 | $-90.68M | $14.69M | (m) | $15.35M | (m) | -617.31% |
| 2021-06-30 | $-21.87M | (m) | (m) | $10.16M | (m) | (m) |
| 2021-03-31 | $-7.84M | (m) | (m) | $12.99M | (m) | (m) |
| 2020-12-31 | $-6.36M | $15.00M | (m) | $12.59M | (m) | -42.38% |
| 2020-09-30 | $-5.38M | (m) | (m) | $11.49M | (m) | (m) |
| 2020-06-30 | $-4.48M | (m) | (m) | $10.35M | (m) | (m) |
| 2020-03-31 | $-19.72M | (m) | (m) | $9.07M | (m) | (m) |
| 2019-12-31 | $-24.44M | (m) | (m) | $12.82M | (m) | (m) |
| 2019-09-30 | $-28.65M | (m) | (m) | $15.94M | (m) | (m) |
| 2019-06-30 | $-12.49M | (m) | (m) | $17.45M | (m) | (m) |
| 2019-03-31 | $-12.55M | (m) | (m) | $19.41M | (m) | (m) |
| 2018-12-31 | $-11.18M | $20.16M | (m) | $17.85M | (m) | -55.47% |
| 2018-09-30 | $-8.60M | (m) | (m) | $16.38M | (m) | (m) |
| 2018-06-30 | $-24.56M | (m) | (m) | $14.98M | (m) | (m) |
| 2018-03-31 | $-24.11M | (m) | (m) | $13.92M | (m) | (m) |
| 2017-12-31 | $-21.39M | (m) | (m) | $12.15M | (m) | (m) |
| 2017-09-30 | $-1.80M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $-1.79M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $-583.63K | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-29.49K | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $-23.02K | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $-23.01K | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $-23.01K | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $-23.01K | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $-23.16K | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $-23.59K | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $-23.80K | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $-23.97K | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $-22.30K | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $-22.01K | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $-22.16K | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $-22.82K | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $-23.11K | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $-23.39K | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $-22.97K | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $-22.39K | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | $-22.04K | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $-22.72K | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $-23.55K | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $-23.59K | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-20.51K | (m) | (m) | (m) | (m) | (m) |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |